Trials / Sponsors / Chen Suning
Chen Suning
Academic / Other · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2024-12-25 |
| Recruiting | RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. ALL, Adult, Philadelphia-Negative ALL | Phase 2 | 2024-02-05 |
| Unknown | The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT COVID-19, Hematopoietic Stem Cell Transplantation | — | 2022-12-26 |
| Unknown | A Study of Olverembatinib in the Treatment of Ph+ ALL Philadelphia-Positive ALL | Phase 2 | 2022-10-01 |
| Completed | Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-AL B Acute Lymphoblastic Leukemia | Phase 2 | 2022-09-08 |
| Active Not Recruiting | Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML AML, Adult, Chemotherapy Effect | Phase 3 | 2022-03-01 |